A detailed history of Douglas Lane & Associates, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 290,345 shares of ILMN stock, worth $40.7 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
290,345
Previous 257,073 12.94%
Holding current value
$40.7 Million
Previous $26.8 Million 41.09%
% of portfolio
0.53%
Previous 0.39%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$105.28 - $135.9 $3.5 Million - $4.52 Million
33,272 Added 12.94%
290,345 $37.9 Million
Q2 2024

Jul 08, 2024

SELL
$101.05 - $133.57 $217,964 - $288,110
-2,157 Reduced 0.83%
257,073 $26.8 Million
Q1 2024

Apr 11, 2024

BUY
$127.73 - $147.2 $241,409 - $278,208
1,890 Added 0.73%
259,230 $35.6 Million
Q4 2023

Jan 17, 2024

SELL
$92.79 - $142.53 $3.18 Million - $4.88 Million
-34,242 Reduced 11.74%
257,340 $35.8 Million
Q3 2023

Oct 16, 2023

SELL
$128.91 - $192.44 $741,232 - $1.11 Million
-5,750 Reduced 1.93%
291,582 $40 Million
Q2 2023

Jul 19, 2023

SELL
$183.43 - $232.67 $1.08 Million - $1.37 Million
-5,893 Reduced 1.94%
297,332 $55.7 Million
Q1 2023

Apr 17, 2023

SELL
$193.75 - $232.55 $334,993 - $402,078
-1,729 Reduced 0.57%
303,225 $70.5 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $163,460 - $211,912
-873 Reduced 0.29%
304,954 $61.7 Million
Q4 2022

Jan 17, 2023

SELL
$187.24 - $242.74 $2.38 Million - $3.09 Million
-12,712 Reduced 3.99%
305,827 $61.8 Million
Q3 2022

Oct 14, 2022

SELL
$177.23 - $227.44 $301,645 - $387,102
-1,702 Reduced 0.53%
318,539 $60.8 Million
Q2 2022

Jul 18, 2022

BUY
$181.58 - $368.0 $922,244 - $1.87 Million
5,079 Added 1.61%
320,241 $59 Million
Q1 2022

Apr 25, 2022

SELL
$303.87 - $423.8 $127,625 - $177,996
-420 Reduced 0.13%
315,162 $110 Million
Q4 2021

Jan 25, 2022

BUY
$347.28 - $421.83 $614,685 - $746,639
1,770 Added 0.56%
315,582 $120 Million
Q3 2021

Oct 21, 2021

SELL
$405.61 - $524.84 $3.55 Million - $4.59 Million
-8,754 Reduced 2.71%
313,812 $127 Million
Q2 2021

Jul 19, 2021

SELL
$372.84 - $481.5 $2.07 Million - $2.67 Million
-5,539 Reduced 1.69%
322,566 $153 Million
Q1 2021

Apr 19, 2021

SELL
$361.28 - $504.76 $3.79 Million - $5.3 Million
-10,497 Reduced 3.1%
328,105 $126 Million
Q4 2020

Jan 14, 2021

SELL
$292.7 - $370.96 $1.97 Million - $2.5 Million
-6,745 Reduced 1.95%
338,602 $125 Million
Q3 2020

Oct 19, 2020

SELL
$268.51 - $400.74 $1.65 Million - $2.46 Million
-6,136 Reduced 1.75%
345,347 $107 Million
Q2 2020

Jul 28, 2020

SELL
$256.46 - $373.01 $2.14 Million - $3.12 Million
-8,359 Reduced 2.32%
351,483 $130 Million
Q1 2020

Apr 20, 2020

SELL
$209.2 - $335.53 $826,758 - $1.33 Million
-3,952 Reduced 1.09%
359,842 $98.3 Million
Q4 2019

Jan 27, 2020

SELL
$288.29 - $335.49 $494,993 - $576,036
-1,717 Reduced 0.47%
363,794 $121 Million
Q3 2019

Oct 16, 2019

SELL
$266.84 - $378.23 $434,682 - $616,136
-1,629 Reduced 0.44%
365,511 $111 Million
Q2 2019

Jul 08, 2019

SELL
$300.59 - $368.15 $2.75 Million - $3.37 Million
-9,148 Reduced 2.43%
367,140 $135 Million
Q1 2019

Apr 23, 2019

SELL
$272.57 - $321.18 $1.88 Million - $2.22 Million
-6,910 Reduced 1.8%
376,288 $117 Million
Q4 2018

Jan 17, 2019

SELL
$272.46 - $366.54 $5.7 Million - $7.67 Million
-20,916 Reduced 5.18%
383,198 $115 Million
Q3 2018

Oct 09, 2018

SELL
$279.04 - $367.06 $5.3 Million - $6.98 Million
-19,009 Reduced 4.49%
404,114 $148 Million
Q2 2018

Jul 23, 2018

SELL
$228.17 - $292.07 $3.48 Million - $4.46 Million
-15,261 Reduced 3.48%
423,123 $118 Million
Q1 2018

Apr 23, 2018

SELL
$209.54 - $253.91 $1.62 Million - $1.97 Million
-7,746 Reduced 1.74%
438,384 $104 Million
Q4 2017

Jan 24, 2018

SELL
$202.23 - $230.03 $1.71 Million - $1.95 Million
-8,462 Reduced 1.86%
446,130 $97.5 Million
Q3 2017

Oct 19, 2017

BUY
$172.3 - $213.93 $78.3 Million - $97.3 Million
454,592
454,592 $90.6 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.